Iowa State University is one of thirteen major Midwestern research universities to participate in the first-ever Midwest Drug Development Conference being held October 1 – 2, 2018 in the Downtown Capitol District, Omaha, NE. The goal of the conference is to provide a one-stop opportunity for industry representatives and investors to learn about therapies developed at Midwestern universities and startup companies.

Iowa State University is set to promote a number of technologies at the event, including treatments for neurodegenerative diseases, epilepsy, and spinal muscle atrophy.  Details about the event can be found at